טוען...
Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C
An estimated 300 million people worldwide suffer from chronic hepatitis C with a prevalence of 0.8%-1.0% of the general population in Canada. An increasing pool of evidence exists supporting the use of pegylated- interferon (pegIFN) and ribavirin combination therapy for hepatitis C. We report a 49-y...
שמור ב:
| Main Authors: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Baishideng Publishing Group Co., Limited
2006
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4087632/ https://ncbi.nlm.nih.gov/pubmed/16937480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v12.i30.4908 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|